Intracytoplasmic sperm injection in Tunisia (ICSI) is a medically assisted reproduction (MAP) technique used to treat fertility problems linked to severe sperm abnormalities. The procedure involves the direct injection of a viable sperm into an oocyte to facilitate fertilisation and the formation of an embryo. ICSI is often recommended when the male partner’s sperm has abnormalities such as low concentration, poor motility or abnormal morphology, which can hinder natural fertilisation.
In Tunisia, the price of ICSI is generally more affordable than in many other countries, making it an attractive option for couples seeking fertility treatment. The costs associated with ICSI can vary depending on various factors, such as the clinic chosen, the doctor’s experience, the drugs used and the laboratory tests required. However, despite its more affordable cost, the quality of medical services and facilities in Tunisia is often high.
ICSI in Tunisia is recommended for couples facing fertility problems linked to severe sperm abnormalities in the male partner. Reasons why a couple might opt for ICSI include:
- Low sperm count
- Low sperm motility
- Abnormal sperm morphology
- A history of fertilisation failure with other MAP methods such as in vitro fertilisation (IVF)
- Unexplained fertility problems despite extensive investigations
L’ICSI offre une solution efficace pour surmonter ces défis en permettant la fécondation directe de l’ovocyte avec un spermatozoïde, contournant ainsi les obstacles rencontrés par le sperme lors de la fertilisation naturelle.
Ovarian stimulation
The first stage of ICSI in Tunisia involves controlled ovarian stimulation. This phase aims to stimulate the woman’s ovaries to produce several mature follicles containing oocytes. Medication is prescribed to regulate and increase oocyte production. During this period, hormone levels are closely monitored by ultrasound scans and blood tests to adjust medication doses if necessary.
Oocyte puncture
Once the follicles are sufficiently mature, a follicular puncture is scheduled. This procedure is carried out under light anaesthetic and guided by ultrasound. Using a fine needle, the oocytes are aspirated from the follicles directly through the vaginal wall.
Sperm collection
At the same time as the oocytes are retrieved, sperm is collected from the male partner. If necessary, sperm may also be obtained by testicular biopsy in cases of azoospermia.
ICSI fertilisation
Once the oocytes and sperm have been collected, ICSI fertilisation is carried out in the laboratory. An embryologist selects a healthy, mobile sperm and injects it directly into the oocyte using a micro-needle. This technique is designed to ensure fertilisation even in the presence of problems with sperm mobility or morphology.
Transferring the embryos to the uterus
After fertilisation, the embryos obtained are cultured in the laboratory for a few days. One or two embryos of optimal quality are then transferred to the woman’s uterus using a thin catheter. This stage is generally painless and requires no anaesthetic.
Luteal support
After the embryo transfer, luteal support treatment may be prescribed to help maintain a favourable uterine environment for implantation and maintenance of the pregnancy. This may include hormone supplements such as progesterone.
Operating suites
After the ICSI procedure, patients may experience mild symptoms such as abdominal cramps, light bleeding or feelings of swelling. These side effects are generally temporary and disappear rapidly. Patients are generally allowed to resume their normal activities shortly after the procedure, although certain post-operative recommendations may be provided by the medical team.
For more information, feel free to contact us.